Therefore, the decrease of HSPB1 in serum of patients with coronary artery disease may be caused by over‐activation of protease, or excessive consumption of HSPB1 caused by anti‐ferroptosis in the body in the process of atherosclerosis plaque formation, which needs further study. Here, HSPB1 is linked to atherosclerosis.